{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:08:42Z","timestamp":1761311322343},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,5,15]]},"DOI":"10.2169\/internalmedicine.0139-17","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T22:14:48Z","timestamp":1515622488000},"page":"1463-1468","source":"Crossref","is-referenced-by-count":9,"title":["Cerebral Toxoplasmosis Diagnosed by Nested-polymerase Chain Reaction in a Patient with Rheumatoid Arthritis"],"prefix":"10.2169","volume":"57","author":[{"given":"Jun","family":"Matsuura","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Saiseikai Shigaken Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Mizuta","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Norose","sequence":"additional","affiliation":[{"name":"Department of Infection and Host Defense, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet (London, England) 363: 1965-1976, 2004.","DOI":"10.1016\/S0140-6736(04)16412-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159: 736-740, 1989.","DOI":"10.1093\/infdis\/159.4.736"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mikita K, Maeda T, Ono T, Miyahira Y, Asai T, Kawana A. The utility of cerebrospinal fluid for the molecular diagnosis of toxoplasmic encephalitis. Diagn Microbiol Infect Dis 75: 155-159, 2013.","DOI":"10.1016\/j.diagmicrobio.2012.10.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lewis JM, Clifford S, Nsutebu E. Toxoplasmosis in immunosuppressed patients. Rheumatology (Oxford) 54: 1939-1940, 2015.","DOI":"10.1093\/rheumatology\/kev115"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Young JD, McGwire BS. Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med 353: discussion 1530-1531, 2005.","DOI":"10.1056\/NEJMc051556"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lassoued S, Zabraniecki L, Marin F, Billey T. Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum 36: 262-263, 2007.","DOI":"10.1016\/j.semarthrit.2006.08.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Horiuchi K, Yabe I, Tajima Y, et al. [Case of toxoplasma encephalopathy with specific MRI findings, diagnosed by IgG avidity index and nested PCR]. Rinsho Shinkeigaku (Clin Neurol) 50: 252-256, 2010 (in Japanese).","DOI":"10.5692\/clinicalneurol.50.252"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nardone R, Zuccoli G, Brigo F, Trinka E, Golaszewski S. Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis. Rheumatology (Oxford) 53: 284, 2014.","DOI":"10.1093\/rheumatology\/ket364"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pulivarthi S, Reshi RA, McGary CT, Gurram MK. Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis. Intern Med 54: 1433-1436, 2015.","DOI":"10.2169\/internalmedicine.54.3977"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, Liso V. Spontaneous remission of &quot;methotrexate-associated lymphoproliferative disorders&quot; after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26: 1-9, 2009.","DOI":"10.1007\/s12032-008-9069-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Grigg ME, Boothroyd JC. Rapid identification of virulent type I strains of the protozoan pathogen <i>Toxoplasma gondii<\/i> by PCR-restriction fragment length polymorphism analysis at the <i>B1<\/i> gene. J Clin Microbiol 39: 398-400, 2001.","DOI":"10.1128\/JCM.39.1.398-400.2001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Alfonso Y, Fraga J, Cox R, Bandera F, Pomier O, Fonseca C, Ginorio D, Torres G, Capo V. Comparison of four DNA extraction methods from cerebrospinal fluid for the detection of <i>Toxoplasma gondii<\/i> by polymerase chain reaction in AIDS patients. Med Sci Monit 14: MT1-MT6, 2008.","DOI":"10.1186\/1743-8454-6-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mesquita RT, Ziegler AP, Hiramoto RM, Vidal JE, Pereira-Chioccola VL. Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients. J Med Microbiol 59 (Pt 6): 641-647, 2010.","DOI":"10.1099\/jmm.0.016261-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yamada H, Nishikawa A, Yamamoto T, et al. Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods. J Clin Microbiol 49: 2552-2556, 2011.","DOI":"10.1128\/JCM.02092-10"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Anselmo LM, Vilar FC, Lima JE, Yamamoto AY, Bollela VR, Takayanagui OM. Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients. J Neurol Sci 346: 231-234, 2014.","DOI":"10.1016\/j.jns.2014.08.034"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 27: 2133-2135, 1989.","DOI":"10.1128\/JCM.27.9.2133-2135.1989"},{"key":"17","unstructured":"17. Fuccillo DA, Madden DL, Tzan N, Sever JL. Difficulties associated with serological diagnosis of <i>Toxoplasma gondii<\/i> infections. Diagn Clin Immunol 5: 8-13, 1987."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/10\/57_0139-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T12:58:44Z","timestamp":1603630724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/10\/57_0139-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0139-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]}}}